abstract |
(57) Abstract: [PROBLEMS] To provide a highly effective therapeutic agent with few side effects on methicillin-resistant Staphylococcus aureus infection. A therapeutic agent for methicillin-resistant Staphylococcus aureus infection comprising, as an active ingredient, one or more compounds selected from the group consisting of lupron, colpron and adolpron. Lupron, colprone and adolpron are compounds belonging to β-acid which is an extract component of hops. |